Let’s go through some study results
TREMFYA® has been clinically studied and proven effective at helping patients with moderate to severe plaque psoriasis achieve clearer skin and fewer symptoms.
See more results below.
90% CLEARER SKIN AT 16 WEEKS
In clinical studies, at 16 weeks, at least 7 out of 10 patients saw at least 90% clearer skin.
90% CLEARER SKIN AT 48 WEEKS
In a clinical study, nearly 9 out of 10 people who saw 90% clearer skin at 28 weeks continued to see 90% clearer skin at 48 weeks.
90% CLEARER SKIN AT 5 YEARS
In a study, nearly 7 out of 10 patients with 90% clearer skin at 16 weeks were still clearer at 5 years.
At 1 year and thereafter, patients and healthcare providers knew that TREMFYA® was being used. This may have increased results. Results may vary.
100% CLEARER SKIN AT 16 WEEKS
In one clinical study, 5 out of 10 patients saw completely clear skin at 16 weeks.
IMPROVED SYMPTOMS AT 16 WEEKS
In clinical studies, at 16 weeks, patients had improvements in symptoms of plaque psoriasis including itching, burning, pain, stinging, and skin tightness.
CLEAR OR ALMOST CLEAR SCALP AT 16 WEEKS
In clinical studies, at week 16, 4 out of 5 people with scalp psoriasis were rated clear or almost clear of their scalp psoriasis.
Individual results may vary.
Before & After TREMFYA®
Before & After TREMFYA®
Results don’t appear overnight, but they can be seen at 16 weeks. Take a look at these before and after images to see how TREMFYA® can help.
Photos are of a real patient with moderate to severe plaque psoriasis who received a single dose of TREMFYA® 100 mg at weeks 0 and 4, and then every 8 weeks. Individual results may vary.
TREMFYA® is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis.
Psoriatic arthritis is a chronic, or long-term, disease. It affects about 30% of people with psoriasis. While the exact cause is unknown, when you have psoriatic arthritis, your immune system attacks healthy tissues like the skin and joints.
Click the button below to learn more about how TREMFYA® could help treat adults with active psoriatic arthritis.
Doctor Discussion Guide
Finish each statement below by choosing one or more of the options. Click “Next” to move forward in the guide.
We’ll use your responses to make personalized talking points that you can take with you to your next doctor’s appointment.
Back
Next
Get your own English or Spanish brochure and discussion guide
Doctor Discussion Guide
Take this guide with you to your next dermatologist appointment to have a more productive discussion about your plaque psoriasis.
Guía de Discusión del Médico
Lleve esta guía a su próxima cita con el dermatólogo para tener una discusión más productiva sobre su psoriasis en placas.
TREMFYA® Legacy
Tremfya® has 14+ years of combined clinical research* and 6+ years on the market across indications.
*Based on a clinical trial of TREMFYA® initiated in 2009.
TREMFYA® Safety Information
Ask your doctor about the benefits and risks of TREMFYA®. Prescription medications, including TREMFYA®, have possible risks involved with treatment, so it’s important to discuss them with your doctor.
TREMFYA® may cause serious side effects, including:
- Serious allergic reactions. Stop using TREMFYA® and get emergency medical help right away if you develop any of the following symptoms of a serious allergic reaction:
- fainting, dizziness, feeling lightheaded (low blood pressure)
- swelling of your face, eyelids, lips, mouth, tongue or throat
- trouble breathing or throat tightness
- chest tightness
- skin rash, hives
- itching
- fainting, dizziness, feeling lightheaded
(low blood pressure) - swelling of your face, eyelids, lips,
- mouth, tongue or throat
- trouble breathing or throat tightness
- chest tightness
- skin rash, hives
- itching
- Infections. TREMFYA® is a medicine that may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with TREMFYA® and may treat you for TB before you begin treatment with TREMFYA® if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with TREMFYA®.
Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
- fever, sweats, or chills
- cough
- shortness of breath
- blood in your phlegm (mucus)
- muscle aches
- warm, red, or painful skin or sores on your body different from your psoriasis
- weight loss
- diarrhea or stomach pain
- burning when you urinate or urinating more often than normal
- fever, sweats, or chills
- cough
- shortness of breath
- blood in your phlegm (mucus)
- muscle aches
- warm, red, or painful skin or
sores on your body different
from your psoriasis
- muscle aches
- warm, red, or painful skin or
sores on your body different
from your psoriasis
These are not all the possible side effects of TREMFYA®.
Please read the Important Safety Information located at the bottom of the screen and the Medication Guide for TREMFYA® to learn more about these and other risks for TREMFYA®. Discuss any questions you have with your doctor.
TREMFYA® may cause serious side effects including:
- See “What is the most important information I should know about TREMFYA®?”The most common side effects of TREMFYA® include:
- upper respiratory infections
- joint pain (arthralgia)
- fungal skin infections
- headache
- diarrhea
- herpes simplex infections
- injection site reactions
- stomach flu (gastroenteritis)
- bronchitis
These are not all the possible side effects of TREMFYA®. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
